Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 04, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the Company's Ordinary Shares and American Depositary Receipts (ADRs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of specific share transactions rather than a financial performance report.
Material Changes
The filing details a specific transaction on April 2, 2007, where Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust, transferred 11,514 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The Company was advised of these transactions on April 3, 2007.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr JP Garnier, Dr M M Slaoui, and Mr J S Heslop) are interested in the shares held in the trust in the same capacity as other employees.
Investor Verification Points
- Verify the impact of the 11,514 share transfer on the total outstanding share count.
- Confirm the specific allocation of shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Review the full terms of the GlaxoSmithKline Employee Trust to understand the discretionary nature of the holdings.